COMPANY REPORT

Company Report: China Sunsine Chemical Hlds Ltd (CSSC SP / CSSC.SI)

Publication Date:

03 Jul 2026
OUTPERFORM

CSSC SP / CSSC.SI

China Sunsine Chemical Hlds Ltd

Tyre-chain scale leader with volume resilience and FY26 spread upside

INDUSTRY

Materials

LAST CLOSE (S$)
$ 0
12M TARGET PRICE (S$)
$ 0
UPSIDE / (DOWNSIDE) (%)
+ 0 %

Investment Highlights

INVESTMENT HIGHLIGHT #1

Embedded in a mission-critical tyre input chain.

Sunsine supplies accelerators, insoluble sulphur and anti-oxidants used in compounding and vulcanisation. Rubber chemicals are a small share of tyre cost, but they affect cure speed, durability and production reliability; qualified suppliers therefore have stronger retention than a generic commodity label implies.

INVESTMENT HIGHLIGHT #2

Scale and compliance support share gains through the cycle.

Sunsine is world’s No. 1 global rubber accelerator producer and operates with 254kt of finished annual capacity at end-FY25. We expect capacity to rise to 272kt in FY26E, supporting volume-led growth as weaker producers face utilisation, environmental and working-capital pressure.

INVESTMENT HIGHLIGHT #3

FY26E spread recovery, not permanent supernormal pricing.

The Yanggu outage and sulphur tightness should improve Sunsine’s bargaining position, especially in insoluble sulphur. Our model still assumes only moderate blended ASP uplift and FY27E-FY30E margin normalisation, keeping the earnings case grounded.

Valuation and Risks

VALUATION & ACTION

Outperform Valuation

We initiate coverage on China Sunsine Chemical Holdings Ltd. with an OUTPERFORM rating and a 12-month target price of S$1.145, based on a DCF using 12.0% WACC and 2.0% terminal growth. Our target price implies 69.6%upside from S$0.675.

RISKS

Risks

Key downside risks include (i) rubber chemical ASP pressure and industry overcapacity; (ii) raw-material and energy price volatility; (iii) weaker tyre demand or customer utilisation; (iv) expansion and utilisation execution risk; and (v) FX and capital-allocation risk.